Navigation Links
Caremark Pharmacy Services Receives New URAC Pharmacy Benefit Management and Drug Therapy Management Accreditations
Date:10/3/2007

WOONSOCKET, R.I., Oct. 3 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) announced today that its pharmacy benefit management division, Caremark Pharmacy Services, has received accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. Caremark Pharmacy Services received accreditation in two new categories: Pharmacy Benefit Management and Drug Therapy Management. These are the first voluntary accreditations developed for the industry.

"Our new URAC accreditations demonstrate Caremark's continued commitment to not only meeting our industry's standards, but also to exceeding them," said Howard McLure, President, Caremark Pharmacy Services. "We are pleased that our dedication to patient care, customer service and overall quality has been recognized by URAC, and we look forward to identifying new ways to further our standards of excellence as we move ahead."

"By applying for and receiving Pharmacy Benefit Management and Drug Therapy Management Accreditation, Caremark has demonstrated a commitment to quality health care," said Alan P. Spielman, URAC President and CEO. "Quality health care is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards."

The Pharmacy Benefit Management standards address organizational quality, customer service, communications, disclosure of pricing policies, pharmaceutical distribution, drug utilization management, and formulary/pharmacy and therapeutics committee. URAC's Drug Therapy Management Accreditation standards, developed concurrently with the Pharmacy Benefit Management standards, are designed to help organizations drive appropriate therapeutic outcomes for consumers with a clear focus on a patient safety, outcomes measurement and quality improvement.

URAC's accreditation process for both Pharmacy Benefit Management and Drug Therapy Management includes an application and evaluation process, a rigorous on-site evaluation and assessment by a URAC accreditation team, and review and consideration for accreditation by URAC's Accreditation Committee.

URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit http://www.urac.org.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions and related healthcare services in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of healthcare services in the U.S. The Company is uniquely positioned to effectively manage costs and improve healthcare outcomes through its 6,200 CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations portion of the Company's website, at http://investor.cvs.com , as well as through the pressroom portion of the Company's website, at http://www.cvs.com/pressroom.

Contact: Carolyn Castel

(401) 770-5717

ccastel@cvs.com


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
2. Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies
3. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
4. Pharmacy Care Program Can Increase Medication Adherence in Elderly
5. Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut
6. California Pharmacy Chain Provides Services to Hispanic Community
7. Support Services found to Dramatically Impact Pediatric Health Care
8. Mental Health Services for Children
9. London Emergency Services Receive Wide Appreciation
10. Health and Human Services stockpiles 20 million bird flu Vaccines
11. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology: